OUROFINO S/A (OFSA3) Main Indicators
Basic Data - OFSA3
| Company | OUROFINO S/A |
| Corporate Name | OUROFINO S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Atividade de comercialização de produtos destinados ao setor de saúde animal. |
| Share | OFSA3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 22.60 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 24.85 thousand |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Medicamentos e Outros Produtos |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 04/02/2025 | |
Relative Prices - OFSA3
| Price/Earnings | 9.08 |
| Price/SBV | 1.61 |
| Price/Net Sales | 1.19 |
| Price/CFO | 16.49 |
| Price/FCF | 21.43 |
| Price/Total Assets | 0.88 |
| Price/EBIT | 6.53 |
| Price/Working Capital | 2.03 |
| Price/NCAV | -43.59 |
| EV/EBIT | 7.20 |
| EV/EBITDA | 5.99 |
| EV/Net Sales | 1.31 |
| EV/CFO | 18.19 |
| EV/FCF | 23.63 |
| EV/Total Assets | 0.97 |
| Company Market Cap | R$ 1.22 B |
| Enterprise Value | R$ 1.34 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 22.60 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 13.92% |
| Updated 04/02/2025 | |
Income Statement - OFSA3
| Net Revenue | R$ 1.02 B |
| Gross Result | R$ 517.69 M |
| EBIT | R$ 186.83 M |
| Depreciation and Amortization | - R$ 37.68 M |
| EBITDA | R$ 224.52 M |
| Net Profit | R$ 134.33 M |
| Net Profit/Share | R$ 2.49 |
| Updated 03/17/2025 | |
| Net Revenue | R$ 346.63 M |
| Gross Result | R$ 173.17 M |
| EBIT | R$ 77.23 M |
| Depreciation and Amortization | - R$ 9.88 M |
| EBITDA | R$ 87.11 M |
| Net Profit | R$ 62.98 M |
| Profit/Share | R$ 1.17 |
| Updated 03/17/2025 | |
Price and Volume Behavior - OFSA3
| Lowest Price 52 weeks | R$ 15.88 |
| Highest Price 52 weeks | R$ 22.60 |
| Variation 2025 | 28.70% |
| Variation 1 year | 8.28% |
| Variation 2 years(total) | 10.12% |
| Variation 2 years(yearly) | 4.93% |
| Variation 3 years(total) | 12.40% |
| Variation 3 years(yearly) | 3.97% |
| Variation 4 years(total) | -11.22% |
| Variation 4 years(yearly) | -2.93% |
| Variation 5 years(total) | 30.75% |
| Variation 5 years(yearly) | 5.51% |
| Average Daily Volume (3 months) | R$ 138.45 thousand |
| Updated 04/02/2025 | |
Returns and Margins - OFSA3
| Return on Initial Tangible Capital | 16.47% |
| Return on Initial Invested Capital | 15.09% |
| Pre-Tax Return on Initial Tangible Capital | 24.96% |
| Pre-Tax Return on Initial Invested Capital | 22.86% |
| Return on Initial Shareholder´s Equity | 19.49% |
| Return on Initial Asset | 10.50% |
| Gross Margin | 50.52% |
| Net Margin | 13.11% |
| EBIT Margin | 18.23% |
| EBITDA Margin | 21.91% |
| Initial Asset Turnover | 0.80 |
| Financial Leverage | 1.83 |
| Liabilities/Net Worth | 0.83 |
| Net Debt/EBITDA | 0.56 |
| Updated 03/17/2025 | |
Balance Sheet - OFSA3
| Cash and Cash Equivalents | R$ 233.96 M |
| Total Assets | R$ 1.38 B |
| Short-Term Debt | R$ 56.89 M |
| Long-Term Debt | R$ 302.46 M |
| Gross Debt | R$ 359.35 M |
| Net Debt | R$ 125.40 M |
| Shareholder´s Equity | R$ 756.40 M |
| Share Book Value | R$ 14.02 |
| Common Shares | 53,949,006 |
| Preferred Shares | 0 |
| Total | 53,949,006 |
| Common Shares in Treasury | 181,400 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 181,400 |
| Common Shares (Except Treasury) | 53,767,606 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 53,767,606 |
| Updated 03/17/2025 | |
Cash Flow - OFSA3
| Operating Cash Flow | R$ 73.94 M |
| Cash Flow from Investments | - R$ 42.88 M |
| Financing Cash Flow | - R$ 102.17 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 70.07 M |
| Updated 03/17/2025 | |
| Operating Cash Flow | - R$ 3.36 M |
| Cash Flow from Investments | - R$ 16.70 M |
| Financing Cash Flow | - R$ 5.62 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 25.32 M |
| Updated 03/17/2025 | |
Experimental - OFSA3
| CAPEX 3 months | - R$ 8.41 M |
| Free Cash Flow 3 months | - R$ 11.77 M |
| CAPEX 12 months | - R$ 17.03 M |
| Free Cash Flow 12 months | R$ 56.91 M |
| Updated 03/17/2025 | |